Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
161.32
+0.16 (0.10%)
At close: Nov 20, 2024, 4:00 PM
161.61
+0.29 (0.18%)
Pre-market: Nov 21, 2024, 5:56 AM EST
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $2.49B in the quarter ending September 30, 2024, with 8.41% growth. This brings the company's revenue in the last twelve months to $9.54B, up 2.60% year-over-year. In the year 2023, Quest Diagnostics had annual revenue of $9.25B, down -6.38%.
Revenue (ttm)
$9.54B
Revenue Growth
+2.60%
P/S Ratio
1.88
Revenue / Employee
$198,729
Employees
48,000
Market Cap
17.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
Dec 31, 2019 | 7.73B | 195.00M | 2.59% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Molina Healthcare | 37.54B |
Teva Pharmaceutical | 16.77B |
Baxter International | 15.06B |
Labcorp Holdings | 12.71B |
ICON Public Limited Company | 8.31B |
Hologic | 3.99B |
Align Technology | 3.96B |
The Cooper Companies | 3.80B |
DGX News
- 5 days ago - Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management - Business Wire
- 8 days ago - Quest Diagnostics Declares Quarterly Cash Dividend - PRNewsWire
- 4 weeks ago - Quest Diagnostics Has Massive Secular Tailwinds And A Strong Base - Seeking Alpha
- 4 weeks ago - Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat - Seeking Alpha
- 4 weeks ago - US lab operator Quest Diagnostics to launch bird flu test at end of October - Reuters
- 4 weeks ago - Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development - PRNewsWire
- 4 weeks ago - Quest Diagnostics (DGX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025 - Benzinga